-
Mashup Score: 0Toripalimab Improves PFS in PD-L1+ Recurrent/Metastatic TNBC - 10 month(s) ago
Adding toripalimab to nab-paclitaxel improves progression-free survival in PD-L1+ metastatic/recurrent triple-negative breast cancer, a phase 3 trial suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Prostate radiotherapy added to intensified systemic therapy for de novo low-volume mCSPC decreases the risk of radiographic disease progression.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers have used a geriatric rating scale to show that childhood cancer survivors experience accelerated aging and have a higher risk of premature death than the general population.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Olvimulogene Nanivacirepvec May Reverse Platinum Resistance, Refractoriness in Ovarian Cancer - 10 month(s) ago
Olvimulogene nanivacirepvec plus platinum-based chemotherapy and bevacizumab appears effective in platinum-resistant or -refractory ovarian cancer.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cancer Patients’ Race, Insurance Type May Impact End-of-Life Care - 10 month(s) ago
A cancer patient’s race, type of insurance, and setting in which they are treated are all associated with end-of-life treatment, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2High Prevalence of Cardiovascular Risk Factors in Head and Neck Cancers - 10 month(s) ago
Research suggests a high prevalence of uncontrolled cardiovascular risk factors among patients with head and neck cancers.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Children of Cancer Patients Have Increased Risk of Unmet Economic Needs - 10 month(s) ago
Children who have a parent with cancer are more likely than other children to experience unmet economic needs, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Older, Hispanic Patients More Likely to Withdraw From Cancer Trials - 10 month(s) ago
Cancer patients are more likely to withdraw from clinical trials if they are older, Hispanic, and participating in a placebo-controlled study, new research suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Axi-Cel Outperforms Standard Second-Line Treatment for LBCL - 10 month(s) ago
Second-line treatment with axicabtagene ciloleucel can improve overall survival when compared to standard care in patients with relapsed or refractory large B-cell lymphoma.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cilta-Cel May Be New Standard Care for Lenalidomide-Refractory MM - 10 month(s) ago
Cilta-cel outperformed standard care in patients with lenalidomide-refractory multiple myeloma in the CARTITUDE-4 trial.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Adding toripalimab to nab-paclitaxel improves PFS in patients with PD-L1-positive metastatic or recurrent triple-negative #breastcancer. Presented at the @ASCO #ASCO23. https://t.co/stAXCKvSyR #TNBC